Hippel James
SEC CIK 1603594 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| TECH | Bio-Techne | CFO | 174.5K | — | $19.58M | 37 | 2021-07-12 | 2026-08-15 |
Most active insiders at TECH, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Herr Amy E. | Dir | — | $437.2K |
| 2 | Crouse Steven C. | Pres - Diag, Spatial Bi | — | — |
| 3 | Bohnen Shane | SVP - GC | — | — |
| 4 | McManus Matthew | Pres - Diag, Spatial Bio | — | — |
| 5 | Geist William | Pres, PROTEIN SCIENCES | — | — |
| 6 | Klimovsky Judith V. | Dir | — | — |
| 7 | Kelderman Kim | CEO, Dir | — | — |
| 8 | Seth Alpna | Dir | — | — |
| 9 | Vessey Rupert | Dir | — | — |
| 10 | Hippel James | CFO | — | — |
Transactions 37
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-08-18 17:13 | 2026-08-15 | TECH | Bio-Techne | Hippel James | CFO | M - OptEx | $0.00 | +9,779 | 174.5K | +6% | $0 |
| D | 2026-08-18 17:13 | 2026-08-15 | TECH | Bio-Techne | Hippel James | CFO | F - Tax | $72.40 | -4,310 | 170.2K | -2% | -$312.0K |
| D | 2026-07-31 17:18 | 2026-07-29 | TECH | Bio-Techne | Hippel James | CFO | M - OptEx | $47.60 | +62.1K | 215.7K | +40% | +$2.95M |
| D | 2026-07-31 17:18 | 2026-07-29 | TECH | Bio-Techne | Hippel James | CFO | F - Tax | $72.03 | -51.0K | 164.7K | -24% | -$3.68M |
| D | 2026-05-07 17:26 | 2026-05-05 | TECH | Bio-Techne | Hippel James | CFO | M - OptEx | $47.60 | +62.0K | 210.6K | +42% | +$2.95M |
| D | 2026-05-07 17:26 | 2026-05-05 | TECH | Bio-Techne | Hippel James | CFO | F - Tax | $56.68 | -57.0K | 153.7K | -27% | -$3.23M |
| D | 2026-04-24 18:05 | 2026-04-22 | TECH | Bio-Techne | Hippel James | CFO | M - OptEx | $0.00 | +62.0K | 204.7K | +43% | $0 |
| D | 2026-04-24 18:05 | 2026-04-22 | TECH | Bio-Techne | Hippel James | CFO | F - Tax | $58.58 | -56.1K | 148.6K | -27% | -$3.29M |
| DM | 2025-11-05 | 2025-11-03 | TECH | Bio-Techne | Hippel James | CFO | M - OptEx | $0.00 | +24.7K | 143.0K | +21% | $0 |
| D | 2025-11-05 | 2025-11-03 | TECH | Bio-Techne | Hippel James | CFO | F - Tax | $62.57 | -11.9K | 142.7K | -8% | -$742.4K |
| D | 2025-08-19 | 2025-08-15 | TECH | Bio-Techne | Hippel James | CFO | F - Tax | $53.60 | -1,926 | 129.9K | -1% | -$103.2K |
| D | 2025-08-19 | 2025-08-15 | TECH | Bio-Techne | Hippel James | CFO | M - OptEx | $0.00 | +4,010 | 131.8K | +3% | $0 |
| D | 2025-07-31 | 2025-07-29 | TECH | Bio-Techne | Hippel James | CFO | M - OptEx | $44.33 | +168.6K | 275.2K | +158% | +$7.47M |
| D | 2025-07-31 | 2025-07-29 | TECH | Bio-Techne | Hippel James | CFO | F - Tax | $58.55 | -147.4K | 127.8K | -54% | -$8.63M |
| D | 2024-11-05 | 2024-11-01 | TECH | Bio-Techne | Hippel James | CFO | M - OptEx | $0.00 | +13.2K | 113.1K | +13% | $0 |
| D | 2024-11-05 | 2024-11-01 | TECH | Bio-Techne | Hippel James | CFO | F - Tax | $75.31 | -6,475 | 106.6K | -6% | -$487.6K |
| D | 2024-08-06 | 2024-08-02 | TECH | Bio-Techne | Hippel James | CFO | F - Tax | $82.35 | -36.1K | 99.9K | -27% | -$2.97M |
| D | 2024-08-06 | 2024-08-02 | TECH | Bio-Techne | Hippel James | CFO | M - OptEx | $31.26 | +53.0K | 136.0K | +64% | +$1.66M |
| D | 2024-07-25 | 2024-07-23 | TECH | Bio-Techne | Hippel James | CFO | M - OptEx | $31.26 | +35.0K | 107.3K | +48% | +$1.09M |
| D | 2024-07-25 | 2024-07-23 | TECH | Bio-Techne | Hippel James | CFO | F - Tax | $77.77 | -24.3K | 83.0K | -23% | -$1.89M |
| D | 2023-12-21 | 2023-12-19 | TECH | Bio-Techne | Hippel James | CFO | F - Tax | $77.42 | -33.0K | 71.9K | -31% | -$2.55M |
| D | 2023-12-21 | 2023-12-19 | TECH | Bio-Techne | Hippel James | CFO | M - OptEx | $31.26 | +47.3K | 104.8K | +82% | +$1.48M |
| D | 2023-08-08 | 2023-08-05 | TECH | Bio-Techne | Hippel James | CFO | F - Tax | $82.17 | -6,335 | 57.6K | -10% | -$520.5K |
| D | 2023-08-08 | 2023-08-05 | TECH | Bio-Techne | Hippel James | CFO | M - OptEx | $0.00 | +12.9K | 63.9K | +25% | $0 |
| D | 2022-08-09 | 2022-08-07 | TECH | Bio-Techne | Hippel James | CFO | M - OptEx | $0.00 | +3,938 | 14.7K | +37% | $0 |
| D | 2022-08-09 | 2022-08-07 | TECH | Bio-Techne | Hippel James | CFO | F - Tax | $382.97 | -1,938 | 12.8K | -13% | -$742.2K |
| DM | 2021-11-03 | 2021-11-01+ | TECH | Bio-Techne | Hippel James | CFO | M - OptEx | $125.05 | +9,022 | 19.6K | +85% | +$1.13M |
| DM | 2021-11-03 | 2021-11-01+ | TECH | Bio-Techne | Hippel James | CFO | S - Sale+OE | $526.49 | -9,022 | 16.0K | -36% | -$4.75M |
| DM | 2021-11-01 | 2021-10-28+ | TECH | Bio-Techne | Hippel James | CFO | S - Sale+OE | $525.22 | -762 | 10.8K | -7% | -$400.2K |
| D | 2021-11-01 | 2021-10-29 | TECH | Bio-Techne | Hippel James | CFO | M - OptEx | $125.05 | +662 | 11.4K | +6% | +$82.8K |
| DM | 2021-09-07 | 2021-09-02 | TECH | Bio-Techne | Hippel James | CFO | S - Sale+OE | $507.22 | -10.0K | 10.9K | -48% | -$5.07M |
| D | 2021-09-07 | 2021-09-02 | TECH | Bio-Techne | Hippel James | CFO | M - OptEx | $106.59 | +10.0K | 20.9K | +92% | +$1.07M |
| DM | 2021-08-10 | 2021-08-09 | TECH | Bio-Techne | Hippel James | CFO | S - Sale+OE | $478.90 | -10.0K | 10.9K | -48% | -$4.79M |
| D | 2021-08-10 | 2021-08-08 | TECH | Bio-Techne | Hippel James | CFO | F - Tax | $481.82 | -1,665 | 10.9K | -13% | -$802.2K |
| DM | 2021-08-10 | 2021-08-08+ | TECH | Bio-Techne | Hippel James | CFO | M - OptEx | $79.65 | +13.4K | 12.5K | New | +$1.07M |
| D | 2021-07-14 | 2021-07-12 | TECH | Bio-Techne | Hippel James | CFO | M - OptEx | $106.59 | +10.0K | 19.1K | +109% | +$1.07M |
| DM | 2021-07-14 | 2021-07-12 | TECH | Bio-Techne | Hippel James | CFO | S - Sale+OE | $456.67 | -10.0K | 14.0K | -42% | -$4.57M |
Purchase Sale Sale after option exercise All abbreviations